T-cell developmental blockage by tachykinin antagonists and the role of hemokinin 1 in T lymphopoiesis

Blood

Volumn 102, Issue 6, 2003, Pages 2165-2172

  Zhang, Yu ^a   Paige, Christopher J ^b  

^a PRINCESS MARGARET HOSPITAL   (Canada)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

HEMOKININ 1; TACHYKININ; TACHYKININ RECEPTOR ANTAGONIST; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; AUTOCRINE EFFECT; B LYMPHOCYTE; CELL MATURATION; CELL SURVIVAL; CONTROLLED STUDY; FETUS; LYMPHOCYTE DIFFERENTIATION; LYMPHOCYTE PROLIFERATION; LYMPHOPOIESIS; MOUSE; NONHUMAN; PARACRINE SIGNALING; PRIORITY JOURNAL; PROTEIN LOCALIZATION; T LYMPHOCYTE; THYMUS;

EID: 0141456009     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood-2002-11-3572     Document Type: Article

References (40)

1. Moroy T, Karsunky H. Regulation of pre-T-cell development. Cell Mol Life Sci. 2000;57:957-975.
2. Haks MC, Oosterwegel MA, Blom B, Spits H, Kruisbeek AM. Cell-fate decisions in early T cell development: regulation by cytokine receptors and the pre-TCR. Semin Immunol. 1999;11:23-37.
3. - triple-negative adult mouse thymocytes defined by CD44 and CD25 expression. J Immunol. 1993;150:4244-4252.
4. Shortman K, Wu L. Early T lymphocyte progenitors. Annu Rev Immunol. 1996;14:29-47.
5. Zuniga-Pflucker JC, Di J, Lenardo MJ. Requirement for TNF-alpha and IL-1 alpha in fetal thymocyte commitment and differentiation. Science. 1995;268:1906-1909.
6. + cells. Eur J Immunol. 1988;18:519-523.
7. +) thymocytes in normal and genetically modified mice. J Immunol. 1995;154:5103-5113.
8. Hokfelt T, Pernow B, Wahren J. Substance P: a pioneer amongst neuropeptides. J Intern Med. 2001;249:27-40.
9. Geppetti G, Harrison S. Substance p. Int J Biochem Cell Biol. 2001;33:555-576.
10. Cao YQ, Mantyh PW, Carlson EJ, Gillespie AM, Epstein CJ, Basbaum AI. Primary afferent tachykinins are required to experience moderate to intense pain. Nature. 1998;392:390-394.
11. Zimmer A, Zimmer AM, Baffi J, et al. Hypoalgesia in mice with a targeted deletion of the tachykinin 1 gene. Proc Natl Acad Sci U S A. 1998;95:2630-2635.
12. De Felipe C, Herrero JF, O'Brien JA, et al. Altered nociception, analgesia and aggression in mice lacking the receptor for substance P. Nature. 1998;392:394-397.
13. Bozic CR, Lu B, Hopken UE, Gerard C, Gerard NP. Neurogenic amplification of immune complex inflammation. Science. 1996;273:1722-1725.
14. Rameshwar P, Gascon P. Hematopoietic modulation by the tachykinins. Acta Haematol. 1997;98:59-64.
15. Lambrecht BN, Germonpre PR, Everaert EG, et al. Endogenously produced substance P contributes to lymphocyte proliferation induced by dendritic cells and direct TCR ligation. Eur J Immunol. 1999;29:3815-3825.
16. Dimri R, Sharabi Y, Shoham J. Specific inhibition of glucocorticoid-induced thymocyte apoptosis by substance P. J Immunol. 2000;164:2479-2486.
17. Levite M. Neuropeptides, by direct interaction with T cells, induce cytokine secretion and break the commitment to a distinct T helper phenotype. Proc Natl Acad Sci U S A. 1998;95:12544-12549.
18. Zhang Y, Lu L, Furlonger C, Wu GE, Paige CJ. Hemokinin is a hematopoietic-specific tachykinin that regulates B lymphopoiesis. Nat Immunol. 2000;1:392-397.
19. Kurtz M, Wang R, Clements M, et al. Identification, localization and receptor characterization of novel mammalian substance-like peptides. Gene. 2002;296:205-212.
20. Muljo SA, Schlissel MS. Pre-B and pre-T-cell receptors: conservation of strategies in regulating early lymphocyte development. Immunol Rev. 2000;175:80-93.
21. Hofmeister R, Khaled AR, Benbemou N, Rajnavolgyi E, Muegge K, Durum SK. Interleukin-7: physiological roles and mechanisms of action. Cytokine Growth Factor Rev. 1999;10:41-60.
22. MacLeod AM, Merchant KJ, Cascieri MA, et al. N-acyl-L-tryptophan benzyl esters: potent substance P receptor antagonists. J Med Chem. 1993;36:2044-2045.
23. Emonds-Alt X, Doutremepunich DJ, Heaulme M, et al. In vitro and in vivo biological activities of SR140333, a novel potent non-peptide tachykinin NK1 receptor antagonist. Eur J Pharmacol. 1993;250:403-413.
24. Gruber J, Sgonc R, Hu YH, Beug H, Wick G. Thymocyte apoptosis induced by elevated endogenous corticosterone levels. Eur J Immunol. 1994;24:1115-1121.
25. +]i mobilisation, cardiovascular and dural extravasation assays. Eur J Pharmacol. 1996;317:129-135.
26. Morteau O, Lu B, Gerard C, Gerard NP. Hemokinin is a full agonist at the substance P receptor. Nat Immunol. 2001;2:1088.
27. Bellucci F, Carini F, Catalani S, et al. Pharmacological profile of the novel mammalian tachykinin, hemokinin 1. Br J Pharmacol. 2002;135:266-274.
28. Camarda V, Rizzi A, Calo G, Guerrini R, Salvadori S, Regoli D. Pharmacological profile of hemokinin 1: a novel member of the tachykinin family. Life Sci. 2002;71:363-370.
29. -/- mice. J Immunol. 1996;157:2366-2373.
30. Rich BE. Autocrine expression of interleukin-7 rescues lymphoid expansion in interleukin-7-deficient mice. Immunology. 1997;92:374-380.
31. -/- mice in the absence of TCR beta chain expression. Int Immunol. 1994;6:995-1001.
32. Lorton D, Bellinger DL, Felten SY, Felten DL. Substance P innervation of the rat thymus. Peptides. 1990;11:1269-1275.
33. Rodewald HR, Kretzchmar K, Swat W, Takeda S. Intrathymically expressed c-kit ligand (stem cell factor) is a major factor driving expansion of very immature thymocytes in vivo. Immunity. 1995;3:313-319.
34. Rodewald HR, Ogawa M, Haller C, Waskow C, DiSanto JP. Pro-thymocyte expansion by c-kit and the common cytokine receptor gamma chain is essential for repertoire formation. Immunity. 1997;6:265-272.
35. + distinguished the early growth response (Egr)-1 transgenic mice with a recombinase-activating gene-deficient background. J Exp Med. 1997;186:877-885.
36. Okamura RM, Sigvarsson M, Galceran J, Verbeek S, Clevens H, Grosschedl R. Redundant regulation of T cell differentiation and TCRalpha gene expression by the transcription factors LEF-1 and TCF-1. Immunity. 1998;8:11-20.
37. Regoli D, Boudon A, Fauchere JL. Receptors and antagonists for substance P and related peptides. Pharmacol Rev. 1994;46:551-599.
38. Shigematsu K, Saavedra JM, Kurihara M. Specific substance P binding sites in rat thymus and spleen: in vitro autoradiographic study. Regul Pept. 1986;16:147-156.
39. Elands J, Resink A, De Kloet ER. Neurohypophyseal hormone receptors in the rat thymus, spleen, and lymphocytes. Endocrinology. 1990;126:2703-2710.
40. Donaldson LF, Haskell CA, Hanley MR. Functional characterization by heterologous expression of a novel cloned tachykinin peptide receptor. Biochem J. 1996;320:1-5.